MustGrow Biologics Corp. Stock Canadian Securities Exchange

Equities

MGRO

CA62822A1030

Biotechnology & Medical Research

Delayed Canadian Securities Exchange 5-day change 1st Jan Change
- CAD -.--% Intraday chart for MustGrow Biologics Corp. +6.74% -28.57%
Sales 2022 6.48K 4.73K Sales 2023 4.71M 3.44M Capitalization 66.39M 48.51M
Net income 2022 -5M -3.65M Net income 2023 - 0 EV / Sales 2022 26,167 x
Net cash position 2022 6.26M 4.57M Net cash position 2023 6.06M 4.43M EV / Sales 2023 12.8 x
P/E ratio 2022
-31.2 x
P/E ratio 2023
-95.1 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 86.21%
More Fundamentals * Assessed data
Dynamic Chart
MustGrow Biologics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
MustGrow Biologics Corp.(TSXV:MGRO) dropped from S&P/TSX Venture Composite Index CI
Mustgrow Biologics Corp. Announces the Signing of Collaboration Agreement with Bayer AG CI
MustGrow Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
MustGrow Biologics Corp. Receives Registration Approval for TerraSante in Washington State CI
MustGrow Biologics Corp. Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT Program CI
MustGrow Biologics Corp. Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment Technology CI
MustGrow Biologics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
MustGrow Biologics Corp.(TSXV:MGRO) added to S&P/TSX Venture Composite Index CI
MustGrow Biologics Corp. Completes Initial Commercial Production Run Via Contract Manufacturer CI
Mustgrow Biologics Corp. Announce the Signing of Contract Services Agreement with Bio Ag Product Strategies CI
MustGrow Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
MustGrow Biologics Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
MustGrow Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
More news
Managers TitleAgeSince
Chief Executive Officer 46 18-03-14
Director of Finance/CFO 58 18-12-16
Chief Operating Officer 49 18-03-14
Members of the board TitleAgeSince
Director/Board Member 50 19-07-16
Chairman 64 18-03-14
Chief Executive Officer 46 18-03-14
More insiders
MustGrow Biologics Corp. is a Canada-based agricultural biotechnology company focused on providing science-based biological solutions for high-value crops. The Company is engaged in developing organic biocontrol, soil amendment and bio fertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply. It focuses on the development and commercialization of natural biological technologies and products from mustard seed for sustainable agricultural markets. The Company is providing a natural, organic technology platform with the efficacy of synthetic chemicals that has potential application in multiple global markets. Its technology pipeline includes soil amendment & bio fertility, biocontrol, and postharvest biocontrol & food preservation. The Company is pursuing the adoption and use of its technology in the soil amendment and bio fertility markets.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.1
Average target price
-
Consensus